FIELD: biotechnology.
SUBSTANCE: invention relates to bispecific antibody that binds to IL-1β and IL18, as well as the method of obtaining it.
EFFECT: invention is effective for treatment of disorders associated with inflammasomes.
7 cl, 11 dwg, 15 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
BISPECIFIC ANTIBODY | 2020 |
|
RU2814713C2 |
MONOCLONAL ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT WHICH SPECIFICALLY BINDS TO 4Rα (GD2 GANGLIOSIDE) AND ITS USE | 2021 |
|
RU2808563C2 |
BISPECIFIC ANTIBODY | 2019 |
|
RU2796019C2 |
ANTI-CEACAM1 ANTIBODY AND ITS APPLICATION | 2018 |
|
RU2754876C2 |
ANTI-IL-5 ANTIBODIES | 2017 |
|
RU2758008C2 |
HUMAN MONOCLONAL ANTIBODIES TO HUMAN INTERLEUKINE-4 (hIL-4) | 2005 |
|
RU2382049C2 |
ANTIBODIES SPECIFIC TO FLT3 AND THEIR APPLICATIONS | 2018 |
|
RU2758513C2 |
ADVANCED PROCOAGULANT ANTIBODIES | 2019 |
|
RU2810748C2 |
ANTIBODIES SPECIFIC TO MMP9 | 2015 |
|
RU2714043C2 |
MONOCLONAL ANTIBODIES TO INTERLEUKIN-31 FOR VETERINARY USE | 2019 |
|
RU2795411C2 |
Authors
Dates
2023-05-02—Published
2018-06-08—Filed